Abstract
The present study was undertaken to develop an in-house enzyme-linked immunosorbent assay (ELISA) using human leukocyte antigen class II restricted epitopes to test circulating autoantibodies to CD25 as a biomarker for esophageal cancer.
Original language | English |
---|---|
Pages (from-to) | 825-9 |
Number of pages | 5 |
Journal | Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico |
Volume | 15 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2013 |